19.05.2025 • Book

3D Printing of Pharmaceutical and Drug Delivery Devices: Progress from Bench to Bedside

3D Printing of Pharmaceutical and Drug Delivery Devices: Progress from Bench to Bedside; June 2024, Wiley; 272 pages, £150,00; ISBN: 978-1-119-83597-4

Authors: Dimitrios A. Lamprou (Editor), Dennis Douroumis (Editor), Sheng Qi (Editor)

Photo
© Wiley

3D printing has revolutionized manufacturing. Its precision and flexibility have enabled the large-scale production of materials and devices too complex for conventional industrial manufacturing. This has been particularly revolutionary in the field of pharmaceutical production, where 3D printing is being integrated into the manufacture of both drugs and drug delivery devices. It has never been more important for industry professionals to understand this form of production.

3D Printing of Pharmaceuticals and Drug Delivery Devices: Progress from Bench to Bedside offers a comprehensive overview of 3D printing technology and its pharmaceutical applications. It introduces readers to a world in which bespoke drug delivery systems developed for specific users or conditions is rapidly becoming a reality. Its detailed coverage of strategies and industrial processes incorporates the latest research and real-world experience of production.

3D Printing of Pharmaceuticals and Drug Delivery Devices: Progress from Bench to Bedside readers will also find:

  • A multi-disciplinary authorial team of industry leaders
  • Discussion of common technical and regulatory barriers and their possible solutions
  • Far-ranging discussion of pharmaceutical applications across all sectors

3D Printing of Pharmaceuticals and Drug Delivery Devices: Progress from Bench to Bedside is essential reading for pharmaceutical industry professionals and researchers looking to occupy the leading edge.

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read